Targeting KIR as a novel approach to improve CAR-NK cell function (2023)
Attributed to:
Using MHC class I peptides to modulate NK cell activity, as a basis for immunotherapy
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.20517/jtgg.2023.25
Publication URI: https://api.elsevier.com/content/abstract/scopus_id/85180328483
Type: Journal Article/Review
Parent Publication: Journal of Translational Genetics and Genomics
Issue: 4